`ESTTA178778
`ESTTA Tracking number:
`12/05/2007
`
`Filing date:
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`BEFORE THE TRADEMARK TRIAL AND APPEAL BOARD
`Petition for Cancellation
`
`Notice is hereby given that the following party requests to cancel indicated registration.
`Petitioner Information
`
`Name
`Entity
`Address
`
`Cell Genesys, Inc.
`Corporation
`500 Forbes Boulevard
`South San Francisco, CA 94080
`UNITED STATES
`
`Citizenship
`
`Delaware
`
`Attorney
`information
`
`Chelseaa Bush
`Heller Ehrman LLP
`333 Bush Street
`San Francisco, CA 94104
`UNITED STATES
`sf-trademark@hellerehrman.com Phone:415-772-6000
`Registration Subject to Cancellation
`
`Registration No
`International
`Registration No.
`Registrant
`
`2717137
`NONE
`
`Registration date
`International
`Registration Date
`
`05/20/2003
`NONE
`
`Genesis Biomedical Limited
`2nd Floor 464 Hay Street
`Subiaco WA 6008,
`AUSTRALIA
`Goods/Services Subject to Cancellation
`
`Class 010.
`All goods and services in the class are cancelled, namely: ELECTROTHERAPY DEVICES, NAMELY,
`PULSED ELECTROMAGNETIC FIELD THERAPEUTIC DEVICES; APPARATUS AND
`INSTRUMENTS FOR DELIVERING OF THERAPY FOR MUSCULOSKELETAL AND VASCULAR
`DISORDERS; PARTS AND ACCESSORIES FOR THE AFORESAID GOODS
`
`Grounds for Cancellation
`
`Abandonment
`Priority and likelihood of confusion
`
`Trademark Act section 14
`Trademark Act section 2(d)
`
`Marks Cited by Petitioner as Basis for Cancellation
`
`U.S. Registration
`No.
`Registration Date
`
`1772613
`
`05/18/1993
`
`Application Date
`
`12/05/1990
`
`Foreign Priority
`Date
`
`NONE
`
`
`
`Word Mark
`Design Mark
`Description of
`Mark
`Goods/Services
`
`CELL GENESYS
`
`NONE
`
`Class 042. First use: First Use: 1992/09/25 First Use In Commerce: 1992/09/25
`research and product development services concerning biotechnology
`
`U.S. Registration
`No.
`Registration Date
`
`2604222
`
`08/06/2002
`
`Application Date
`
`03/29/2001
`
`Foreign Priority
`Date
`
`NONE
`
`Word Mark
`Design Mark
`Description of
`Mark
`Goods/Services
`
`CELL GENESYS
`
`NONE
`
`Class 005. First use: First Use: 1994/10/24 First Use In Commerce: 1994/10/24
`PHARMACEUTICAL PREPARATIONS IN THE NATURE OF VIRAL VECTORS,
`CANCER VACCINES, PACKAGING CELLS AND CELLS TRANSFORMED
`WITH VIRAL VECTORS, ALL FOR THE TREATMENT OF CANCER,
`AUTOIMMUNE DISEASES, INFECTIOUS DISEASES, INFLAMMATORY
`DISEASES AND GENETIC DISEASES
`
`U.S. Registration
`No.
`Registration Date
`
`2604223
`
`08/06/2002
`
`Application Date
`
`03/29/2001
`
`Foreign Priority
`Date
`
`NONE
`
`Word Mark
`Design Mark
`Description of
`Mark
`Goods/Services
`
`CELL GENESYS
`
`NONE
`
`Class 001. First use: First Use: 1994/10/24 First Use In Commerce: 1994/10/24
`BIOCHEMICAL PREPARATIONS IN THE NATURE OF VIRAL VECTORS,
`PACKAGING CELLS AND CELLS TRANSFORMED WITH VIRAL VECTORS,
`ALL FOR RESEARCH USE
`
`Attachments
`
`76232409#TMSN.gif ( 1 page )( bytes )
`76232410#TMSN.gif ( 1 page )( bytes )
`CancellationCELLGEN.pdf ( 5 pages )(125387 bytes )
`
`Certificate of Service
`
`The undersigned hereby certifies that a copy of this paper has been served upon all parties, at their address
`record by First Class Mail on this date.
`
`Signature
`Name
`Date
`
`/ChelseaaBush/
`Chelseaa Bush
`12/05/2007
`
`
`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE TRADEMARK TRIAL AND APPEAL BOARD
`
`In the Matter of Registration No. 2,717,137
`Trademark: CELLGEN
`
`
`
`Cell Genesys, Inc.,
`
`Petitioner,
`
`v.
`
`Genesis Biomedical Limited,
`
`Respondent.
`
`PETITION FOR CANCELLATION
`
`Cell Genesys, Inc. (“Petitioner”), a Delaware corporation having a principal place
`
`of business at 500 Forbes Boulevard, South San Francisco, California 94080, believes
`
`that it is and will continue to be damaged by Registration No. 2717137 for the mark
`
`CELLGEN in International Class 10 and hereby petitions to cancel the same.
`
`As grounds for cancellation, Petitioner alleges:
`
`l.
`
`Genesis Biomedical Limited (“Respondent”) appears as the Registrant of
`
`Registration No. 2,717,137 for CELLGEN for “electrotherapy devices, namely, pulsed
`
`electromagnetic field therapeutic devices; apparatus and instruments for delivering of
`
`therapy for musculoskeletal and vascular disorders; parts and accessories for the aforesaid
`
`goods” in International Class 10.
`
`2.
`
`Respondent is, upon information and belief, an Australian company having
`
`a place of business at 464 Hay Street, Subiaco, Western Australia 6008, Australia.
`
`
`
`3.
`
`Upon information and belief, Respondent has not used CELLGEN as a
`
`trademark in the United States for over three consecutive years, if at all, and therefore
`
`Registrant is presumed to have abandoned the CELLGEN mark pursuant to 15 U.S.C. §
`
`1 127.
`
`4.
`
`Petitioner has used the mark CELL GENESYS since at least as early as
`
`1992. Petitioner is the owner of numerous registrations for CELL GENESYS, including
`
`Registration No. 1772613 registered May 18, 1993 for research and product development
`
`services concerning biotechnology with a date of first use of September 25, 1992,
`
`Registration No. 2604222 registered August 6, 2002 for pharmaceutical preparations with
`
`a date of first use of October 24, 1994, and Registration No. 2604223 registered August 6,
`
`2002 for biochemical preparations with a date of first use of October 24, 1994.
`
`4.
`
`There is no issue as to priority. Respondent’s registration is based on its
`
`foreign registration under Section 44(e) and has been granted a priority date of June 6,
`
`2001. The first date of registration and all the dates of first use of Petitioner’s CELL
`
`GENESYS mark are well before the priority date of Respondent’s CELLGEN mark, and
`
`Petitioner’s CELL GENESYS mark therefore has priority over Respondent’s CELLGEN
`
`registration.
`
`5.
`
`Petitioner has provided its goods and services under the mark CELL
`
`GENESYS throughout the United States and has developed exceedingly valuable
`
`goodwill with respect to the CELL GENESYS mark.
`
`
`
`6.
`
`By virtue of its efforts and the expenditure of considerable sums for
`
`promotional and advertising activities and by virtue of the excellence of its goods and
`
`services, Petitioner has gained for its CELL GENESYS mark a most valuable reputation
`
`and has created, in the minds of the buying public, an exclusive association between the
`
`CELL GENESYS mark and its goods and services.
`
`7.
`
`The trademark registered by Respondent, namely, CELLGEN,
`
`is likely to
`
`be confused with Petitioner’s CELL GENESYS mark because the marks are highly
`
`similar in appearance, sound and overall commercial impression.
`
`8.
`
`Respondent has registered CELLGEN as a mark in connection with goods
`
`that are highly related to the goods of Petitioner and such use so nearly resembles
`
`Petitioner’s use as to be likely to cause confusion, to cause mistake or to deceive within
`
`the meaning of l5 U.S.C. § l052(d).
`9.
`A If Respondent is permitted to use CELLGEN for its goods as specified in
`
`the challenged registration, confusion in trade resulting in damage and injury to Petitioner
`
`would be caused and would result by reason of the fact that Respondent’s mark is
`
`confusingly similar to Petitioner’s CELL GENESYS mark. Persons familiar with
`
`Petitioner’s CELL GENESYS mark would be likely to purchase Respondent’s
`
`CELLGEN goods as goods offered and sold by Petitioner. Furthermore, any defect,
`
`objection, or fault found with Respondent’s goods marketed under CELLGEN would be
`
`likely to reflect upon and seriously injure the reputation that Petitioner has established for
`
`its goods offered under its CELL GENESYS mark.
`
`
`
`10.
`
`If Respondent is permitted to maintain the registration herein opposed, it
`
`will continue to hold at least a prima facie exclusive right to use of CELLGEN. Such a
`
`registration would continue to be a source of damage and injury to Petitioner.
`
`WHEREFORE, Petitioner prays that the cancellation be sustained and that
`
`Registration No. 2,717,137 be cancelled.
`
`Dated: Decembe1‘5,20O7
`
`Respectfully submitted,
`HELLER EHRMAN LLP
`
`By: § Bet M.
`
`o man
`Chelseaa E. Larsen
`Attorneys for Cell Genesys, Inc.
`333 Bush Street
`San Francisco, CA 94104
`415-772-6000
`
`Please refer to Our File No.: 21647~OOO1
`
`
`
`CERTIFICATE OF SERVICE
`
`l certify that a copy of the foregoing PETITION FOR CANCELLATION was sewed by
`First Class Mail, on December 5, 2007, on Respondent at the following address:
`
`Genesis Biomedical Limited
`
`464 Hay Street
`Subiaco, Western Australia 6008
`Australia
`
`and on Respondent’s Attorney of Record/Domestic Representative at the following
`address:
`
`Donna J. Bunton
`
`Nixon & Vanderhye P.C.
`1 100 North Glebe Road, 8th floor
`
`Arlington, VA 22201—4714
`
`Dated: December §, 2007
`
`By:
`
`Chelseaa E. L. Bush
`
`Attorneys for Petitioner
`HELLER EHRMAN LLP
`
`333 Bush Street
`
`San Francisco, California 94104